If explanted; give date: n/a (not applicable).The lens remains implanted.Device evaluation: the device was not returned at the manufacturing site as it remains implanted; therefore, product testing could not be performed and the customer¿s reported complaint could not be verified.Manufacturing record review: the manufacturing records for the intraocular lens were reviewed.The product was manufactured according to specifications.The search revealed that no other complaint for this production order number has been received.Conclusion: as a result of the investigation there is no indication of a product quality deficiency.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
|
It was reported that the patient has a post operative (op) refraction +1.50-.50x75 with an intraocular lens (iol).Eye exam using snellen chart: os 20/30 -1 ph: 20/20.Auto refraction: os +1.00 -0.25 x 055.Manifest refraction: os +1.50 -0.50 x 075 add +2.50 dcc: 20/20 ncc: j1+.Patient reports in the left eye, things are not as clear as they were right after surgery.The patient is using eye drops to help with dryness, but that has not made any changes to the vision.Additional information was reported that the iol rotated 10 degrees.Iol axis placement: 177, pre-op best corrected visual acuity (bcva): 20/40.At a 3-month visit ((b)(6) 2020), iol axis placement: 180, bcva os: 20/20+2.In an unscheduled visit on (b)(6) 2020, patient complained of blurry vision.Uncorrected visual acuity (ucdva) os: 20/30, bcdva os: 20/20, and iol axis placement: 170 (10 degrees from last measured at 3 month visit).At this time, there are no plans for intervention.No additional information was provided.
|